In Brief: Alcon v. Staar Surgical
This article was originally published in The Gray Sheet
Executive Summary
Alcon v. Staar Surgical: Firms settle a patent infringement lawsuit filed by Alcon in April 1995 concerning Staar's Mazzocco Patents (U.S. No. 4,573,998 and corresponding foreign patents), which relate to implantation methods of "deformable intraocular lens structures," Staar says. Under the settlement, terms of which were not disclosed, the companies enter a patent and technology cross-license agreement and dismiss all court claims. Alcon's suit sought relief from a requirement to pay royalties on sales of its IOLs, alleging that the Mazzocco patents were invalid and were not infringed by Alcon products...
You may also be interested in...
Executives On The Move: Changes At The Top At Enzolytics, Dyne Therapeutics And Seres Therapeutics
Recent moves in the industry include new chief financial officers at LENZ Therapeutics and Botanix Pharmaceuticals, plus new chief medical officers at Vigil Neuroscience and Voyager Therapeutics.
Israel's Gamida Cell Survives By Selling To Lender
Having finally secured US approval for Omisirge, Gamida was hoping to bag a strategic partner for the cell therapy. A year on, no suitable partner has been identified and the firm is delisting from the NASDAQ and going private.
EU Regulatory Assessors Get AI Boost In Reaching Scientific Decisions
The European Medicines Agency is training scientific staff working for the European medicines regulatory network in how to use a new AI-powered search engine that allows them to easily retrieve information on regulatory precedents.